Status: current, Defined. Date: 31-May 2017. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 1923411000168113 | Revolade (eltrombopag 25 mg) powder for oral liquid, 30 x 25 mg sachets (trade product pack) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 1923421000168118 | Revolade 25 mg powder for oral liquid, 30 sachets | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Revolade 25 mg powder for oral liquid, 30 sachets | Is a | trade product pack | true | Inferred relationship | Some | ||
| Revolade 25 mg powder for oral liquid, 30 sachets | Is a | eltrombopag 25 mg powder for oral liquid, 30 sachets | true | Inferred relationship | Some | ||
| Revolade 25 mg powder for oral liquid, 30 sachets | has TPUU | Revolade 25 mg powder for oral liquid, 25 mg sachet | true | Inferred relationship | Some | 1 | |
| Revolade 25 mg powder for oral liquid, 30 sachets | has TP | Revolade | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Revolade 25 mg powder for oral liquid, 30 sachets | Is a | True | Revolade 25 mg powder for oral liquid, 30 sachets | Inferred relationship | Some |
Reference Sets
Trade product pack reference set
FHIR